Synapse - Irene Cheung

Search Within

Irene Y Cheung

Results (28)

B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors: Results of a phase I study

Journal Article

Modak, S.; Zanzonico, P.; Grkovski, M.; Slotkin, E. K.; Carrasquillo, J. A.; Lyashchenko, S. K.; Lewis, J. S.; Cheung, I. Y.; Heaton, T.; LaQuaglia, M. P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial

Journal Article

Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
JAMA Oncology (2018)

Fulltext@MSK | Save

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Journal Article

Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
OncoImmunology (2018)

Fulltext@MSK | Save

MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy

Journal Article

Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
Oncotarget (2017)

Fulltext@MSK | Save

Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival

Journal Article

Cheung, I. Y.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
OncoImmunology (2017)

Fulltext@MSK | Save

Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT)

Meeting Abstract

Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, I. Y.; Cheung, N. K. V.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
Oncotarget (2016)

Fulltext@MSK | Save

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: A prospective phase II study

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
OncoImmunology (2015)

Fulltext@MSK | Save

Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
International Journal of Cancer (2014)

Fulltext@MSK | Save

Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission

Journal Article

Kushner, B. H.; Cheung, I. Y.; Modak, S.; Kramer, K.; Ragupathi, G.; Cheung, N. K. V.
Clinical Cancer Research (2014)

Fulltext@MSK | Save